跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Moxiforce - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Moxiforce
Approved
STANDARD
Moxiforce
Hanlim Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
818e5b92ea0516be
Company
Hanlim Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
818e5b92ea0516be
Drug Approval Philippines Name
Moxiforce
Product Name
Moxiforce
Registration Number
DRP-11720
Brand Name
Moxiforce
Generic Name
Moxifloxacin (as Hydrochloride)
Dosage Form
Ophthalmic Solution
Dosage Strength
5 mg/mL (0.5%w/v)
Manufacturer
Hanlim Pharm. Co., Ltd.
Importer
JLT Pharma, Inc.
Distributor
JLT Pharma, Inc.
Company Detail Path
/organization/hanlim-pharm-co-ltd
Issuance Date
22 December 2023
Expiry Date
22 April 2027
Pharmacologic Category
Antiinfective (Flouroquinolone)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
818e5b92ea0516be
Type
Standard
Back to Philippines FDA Approvals